CALL : 0333 247 2474
FREE shipping on orders over £50
Accept all card types
Hints Tips & Offers
Currency :
  Back to Posts

The future looks less rosy for sufferers of rosacea

Rosacea is a very common skin condition that in some form affects as many as one in ten women aged 30 to 55. The UK is thought to have the highest rate in the world, with up to 4 million people suffering from the condition due to our sensitive fair skin complexions. The long-term effects of rosacea can make peoples lives a misery and there are plenty of products out there on the market that claim to relieve symptoms but, in reality, relief is minimal.

However, help is now at hand for sufferers from a new product called Rosacure that is specially formulated for excessive blushing, flushing, reddening skin, including rosacea-prone skin.

One of the main triggers of rosacea is UV radiation, which many of us don't think we are at risk of living in rainy Britain. However, 90 per cent of UV rays can penetrate through cloud cover and this little known fact means that we are one of the worst nations for protecting our skin on a daily basis from damaging UV rays. And if you are a sufferer of sensitive skin then this only goes to make the problem worse.

Rosacea is a long-term skin disorder that causes the facial skin tissue to redden, predominantly on the cheeks, nose, forehead and chin. Inflammation of the underlying tissues, including the blood vessels, also occurs and in the early stages skin redness may appear as periodic blushing attacks. However, as the condition progresses sufferers may see angry, below the surface spots and surface water filled pustules can develop, as well as blood vessels becoming more pronounced which show as thread veins on the surface of the skin.

Rosacea tends to run in families and as a result many people mistakenly believe that their ruddy complexion is simply a family characteristic that they must learn to live with. The degree of reddening and the length of an episode tend to increase as our hormonal status alters in life. Although 40 per cent of rosacea sufferers are men, the main sufferers tend to be women who are approaching or going through the menopause, people with fair skin and adults aged 30-60.

In at least 10 per cent of cases rosacea can cause acne-like eruptions with pustules and lumps, and in one per cent, can cause eye problems such as redness, dryness, itching, burning, excess tears and the feeling of having sand in the eye. The eyelids may become inflamed and swollen and the eyes become sensitive to light.

Rosacure helps sufferers by reducing reddening and swelling, increasing the skins resistance and decreasing its sensitivity to triggers. Rosacure also helps to protect by nourishing the skin and improving the skin quality, resulting in more tolerant and calmer skin and making it more resistant to damage, such as thread veins, and encourages recovery.

Rosacure is made using natural-based products and visibly reduces permanent and intermittent redness in just 10 to 14 days. Continued improvement is seen with continued use.

Peter Roberts, managing director of SkinMed who market Rosacure, said: "Rosacea is a common skin condition that people need no longer suffer from. Whilst it is not life threatening, the disorder is debilitating as sufferers have to make changes to their lifestyle, for example, by avoiding going out in sunny weather, avoiding alcohol or by steering clear of strenuous exercise, all of which can cause flare-ups. Rosacure is revolutionary as it uses a new combination of active ingredients that help to visibly reduce redness and provide relief at a rate that has not been available before."

As an added bonus, SkinMed are offering a money back guarantee for anyone who buys Rosacure after pre-assessment carried out by one of SkinMed's qualified advisors.

Case studies are available on request.

For information on Rosacure, visit or call 08701 909369.

Created On  1 Apr 2015 11:23  -  Permalink


No comments available

Leave a Comment

Comments are moderated, and will not appear on this blog until the author has approved them.
Name and email address are required. The email address will not be displayed with the comment.
Your comment
Name *
Email *
Website URL